首页 | 官方网站   微博 | 高级检索  
     

主动靶向脂质体在抗肿瘤治疗中的研究进展
引用本文:程荔春,范青.主动靶向脂质体在抗肿瘤治疗中的研究进展[J].实用药物与临床,2011,14(5).
作者姓名:程荔春  范青
作者单位:大连医科大学附属第二医院药剂科,大连,116027
摘    要:主动靶向脂质体给药系统可使抗肿瘤药物与靶组织结合,将药物可控性地分布于靶组织并持续缓慢释药,在提高药物抗癌效果的同时,降低了其对正常组织的不良反应。本文主要介绍了免疫脂质体、受体介导的脂质体、糖基修饰的脂质体及多肽修饰的脂质体等主动靶向脂质体在抗肿瘤研究中的进展。主动靶向脂质体给药系统将会发展为抗肿瘤药物的理想剂型,具有很好的临床应用前景。

关 键 词:免疫脂质体  糖基修饰的脂质体  受体介导的脂质体  多肽修饰的脂质体

Development of liposomal targeting system in tumor therapy
CHENG Li-chun,FAN Qing.Development of liposomal targeting system in tumor therapy[J].Practical Pharmacy and Clinical Remedies,2011,14(5).
Authors:CHENG Li-chun  FAN Qing
Affiliation:CHENG Li-chun,FAN Qing(Pharmacy Department,The Second Affiliated Hospital of Dalian Medical University,Dalian 116044,China)
Abstract:Liposomal targeting system makes antitumor drug combine with target tissue.Encapsulated into liposomal targeting system,antitumor drug could target and release into the target tissue with controlled character.Targeting system could enhance the effect of antitumor drug and prevent some side effects.This article reviews the development of immunoliposomes,receptor mediated liposomes,glycon containing liposomes,peptide-targeted liposomes briefly,which would be the potential drug delivery system in future tumor ...
Keywords:Immunoliposomes  Glycon containing liposomes  Receptor mediated liposomes  Peptide-targeted liposomes  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号